{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11394191", "DateCompleted": {"Year": "2001", "Month": "07", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1180-4882", "JournalIssue": {"Volume": "26", "Issue": "3", "PubDate": {"Year": "2001", "Month": "May"}}, "Title": "Journal of psychiatry & neuroscience : JPN", "ISOAbbreviation": "J Psychiatry Neurosci"}, "ArticleTitle": "Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.", "Pagination": {"StartPage": "221", "EndPage": "228", "MedlinePgn": "221-8"}, "Abstract": {"AbstractText": ["A combination herbal product containing American ginseng extract, Panax quinquefolium, (200 mg) and Ginkgo biloba extract (50 mg) (AD-FX; CV Technologies, Edmonton, Alta.) was tested for its ability to improve the symptoms of attention-deficit hyperactivity disorder (ADHD).", "Open study.", "36 children ranging in age from 3 to 17 years who fit the diagnostic criteria for ADHD.", "AD-FX capsules were taken twice a day on an empty stomach for 4 weeks. Patients were instructed not to change any other medications during the study.", "At the beginning of the study, after 2 weeks, and then at the end of the 4-week trial, parents completed the Conners' Parent Rating Scale--revised, long version, a questionnaire that assesses a broad range of problem behaviours (and was used as an indication of ADHD symptom severity).", "After 2 weeks of treatment, the proportion of the subjects exhibiting improvement (i.e., decrease in T-score of at least 5 points) ranged from 31% for the anxious-shy attribute to 67% for the psychosomatic attribute. After 4 weeks of treatment, the proportion of subjects exhibiting improvement ranged from 44% for the social problems attribute to 74% for the Conners' ADHD index and the DSM-IV hyperactive-impulsive attribute. Five (14%) of 36 subjects reported adverse events, only 2 of which were considered related to the study medication.", "These preliminary results suggest AD-FX treatment may improve symptoms of ADHD and should encourage further research on the use of ginseng and Ginkgo biloba extracts to treat ADHD symptoms."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Oceanside Functional Medicine Research Institute, Nanaimo, BC."}], "Identifier": [], "LastName": "Lyon", "ForeName": "M R", "Initials": "MR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cline", "ForeName": "J C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Totosy de Zepetnek", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shan", "ForeName": "J J", "Initials": "JJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pang", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Benishin", "ForeName": "C", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Canada", "MedlineTA": "J Psychiatry Neurosci", "NlmUniqueID": "9107859", "ISSNLinking": "1180-4882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": ["diagnosis", "drug therapy", "psychology"], "DescriptorName": "Attention Deficit Disorder with Hyperactivity"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": [], "DescriptorName": "Child, Preschool"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:117-24", "ArticleIdList": ["9342772"]}, {"Citation": "J Pharm Pharmacol. 1992 Jan;44(1):24-7", "ArticleIdList": ["1350623"]}, {"Citation": "Int J Clin Pharmacol Res. 1984;4(2):89-93", "ArticleIdList": ["6469442"]}, {"Citation": "J Int Med Res. 1985;13(6):342-8", "ArticleIdList": ["4076533"]}, {"Citation": "J Ethnopharmacol. 1986 Apr-May;16(1):15-22", "ArticleIdList": ["3528672"]}, {"Citation": "J Abnorm Child Psychol. 1988 Oct;16(5):511-25", "ArticleIdList": ["3235744"]}, {"Citation": "Biochem Pharmacol. 1992 Dec 15;44(12):2395-401", "ArticleIdList": ["1472105"]}, {"Citation": "Neurochem Int. 1992 Jul;21(1):1-5", "ArticleIdList": ["1338897"]}, {"Citation": "J Formos Med Assoc. 1993 Feb;92(2):133-8", "ArticleIdList": ["8101741"]}, {"Citation": "Planta Med. 1993 Aug;59(4):302-7", "ArticleIdList": ["8372143"]}, {"Citation": "Am J Psychiatry. 1993 Dec;150(12):1792-8", "ArticleIdList": ["8238632"]}, {"Citation": "J Pharm Pharmacol. 1994 Apr;46(4):316-8", "ArticleIdList": ["8051617"]}, {"Citation": "Brain Res. 1994 Jun 27;649(1-2):7-11", "ArticleIdList": ["7953656"]}, {"Citation": "Life Sci. 1995;56(4):213-22", "ArticleIdList": ["7823780"]}, {"Citation": "Am J Orthopsychiatry. 1994 Oct;64(4):545-53", "ArticleIdList": ["7847570"]}, {"Citation": "Psychopharmacol Bull. 1995;31(1):147-58", "ArticleIdList": ["7675979"]}, {"Citation": "Life Sci. 1996;58(16):1315-21", "ArticleIdList": ["8614288"]}, {"Citation": "J Am Acad Child Adolesc Psychiatry. 1996 Mar;35(3):319-24", "ArticleIdList": ["8714320"]}, {"Citation": "J Assoc Physicians India. 1995 Nov;43(11):760-3", "ArticleIdList": ["8773035"]}, {"Citation": "Pharmacopsychiatry. 1996 Jul;29(4):150-5", "ArticleIdList": ["8858714"]}, {"Citation": "Psychol Bull. 1997 Jan;121(1):65-94", "ArticleIdList": ["9000892"]}, {"Citation": "Nature. 1997 Apr 24;386(6627):827-30", "ArticleIdList": ["9126740"]}, {"Citation": "JAMA. 1997 Oct 22-29;278(16):1327-32", "ArticleIdList": ["9343463"]}, {"Citation": "Chem Pharm Bull (Tokyo). 1989 Feb;37(2):481-4", "ArticleIdList": ["2743497"]}, {"Citation": "Planta Med. 1989 Oct;55(5):429-33", "ArticleIdList": ["2813579"]}, {"Citation": "Aust N Z J Psychiatry. 1991 Jun;25(2):277-83", "ArticleIdList": ["1652243"]}, {"Citation": "Psychiatr Clin North Am. 1992 Mar;15(1):1-27", "ArticleIdList": ["1347936"]}, {"Citation": "Am J Chin Med (Gard City N Y). 1977 Spring;5(1):1-23", "ArticleIdList": ["322469"]}]}], "History": [{"Year": "2001", "Month": "6", "Day": "8", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "7", "Day": "6", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "8", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11394191", "PMC1408291"]}}], "PubmedBookArticle": []}